Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

244 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Gathering real-world compassionate data to expand eligibility for elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis with N1303K or other rare CFTR variants: a viewpoint.
Burgel PR, Sermet-Gaudelus I, Girodon E, Kanaan R, Le Bihan J, Remus N, Ravoninjatovo B, Grenet D, Porzio M, Houdouin V, Le Clainche-Viala L, Durieu I, Nove-Josserand R, Languepin J, Coltey B, Guillaumot A, Audousset C, Chiron R, Weiss L, Fajac I, Da Silva J, Martin C; French CF Reference Network study group. Burgel PR, et al. Eur Respir J. 2024 Jan 25;63(1):2301959. doi: 10.1183/13993003.01959-2023. Print 2024 Jan. Eur Respir J. 2024. PMID: 38242629 No abstract available.
[Recommendations for the management of bone demineralization in cystic fibrosis].
Sermet-Gaudelus I, Nove-Josserand R, Loeille GA, Dacremont G, Souberbielle JC, Fritsch J, Laurans M, Moulin P, Cortet B, Salles JP, Ginies JL, Guillot M, Perez-Martin S, Ruiz JC, Montagne V, Cohen-Solal M, Cormier C, Garabédian M, Mallet E; Fédération française des centres de ressource et de compétence en mucoviscidose. Sermet-Gaudelus I, et al. Arch Pediatr. 2008 Mar;15(3):301-12. doi: 10.1016/j.arcped.2007.12.003. Epub 2008 Mar 5. Arch Pediatr. 2008. PMID: 18325750 French.
Continuous versus intermittent infusions of ceftazidime for treating exacerbation of cystic fibrosis.
Hubert D, Le Roux E, Lavrut T, Wallaert B, Scheid P, Manach D, Grenet D, Sermet-Gaudelus I, Ramel S, Cracowski C, Sardet A, Wizla N, Deneuville E, Garraffo R. Hubert D, et al. Antimicrob Agents Chemother. 2009 Sep;53(9):3650-6. doi: 10.1128/AAC.00174-09. Epub 2009 Jun 15. Antimicrob Agents Chemother. 2009. PMID: 19528265 Free PMC article. Clinical Trial.
[Bone health in cystic fibrosis].
Sermet-Gaudelus I, Castanet M, Souberbielle JC, Mallet E; Le Groupe de Travail sur Minéralisation Osseuse et Mucoviscidose de la Fédération Française des Centres de Ressource et de Compétence en Mucoviscidose. Sermet-Gaudelus I, et al. Arch Pediatr. 2009 Jun;16(6):616-8. doi: 10.1016/S0929-693X(09)74088-6. Arch Pediatr. 2009. PMID: 19541106 French. No abstract available.
Clinical phenotype and genotype of children with borderline sweat test and abnormal nasal epithelial chloride transport.
Sermet-Gaudelus I, Girodon E, Sands D, Stremmler N, Vavrova V, Deneuville E, Reix P, Bui S, Huet F, Lebourgeois M, Munck A, Iron A, Skalicka V, Bienvenu T, Roussel D, Lenoir G, Bellon G, Sarles J, Macek M, Roussey M, Fajac I, Edelman A. Sermet-Gaudelus I, et al. Am J Respir Crit Care Med. 2010 Oct 1;182(7):929-36. doi: 10.1164/rccm.201003-0382OC. Epub 2010 Jun 10. Am J Respir Crit Care Med. 2010. PMID: 20538955
[French guidelines for sweat test practice and interpretation for cystic fibrosis neonatal screening].
Sermet-Gaudelus I, Munck A, Rota M, Roussey M, Feldmann D, Nguyen-Khoa T; Groupe de travail "Dépistage néonatal" de la Fédération des centres de ressources et de compétences de la mucoviscidose. Sermet-Gaudelus I, et al. Arch Pediatr. 2010 Sep;17(9):1349-58. doi: 10.1016/j.arcped.2010.06.021. Epub 2010 Aug 16. Arch Pediatr. 2010. PMID: 20719482 French.
244 results